Skip to content
StockMarketAgent
Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

TPEX/7595 stock hub

TPEX/7595 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPEX/7595is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
491.5M
Taipei Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPEX/7595
In the news

Latest news · TPEX/7595

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12P50 15.5P75 22.5
Trailing P/En/a
P25 14.4P50 18P75 31.9
ROE-23.3
P25 -16.2P50 0.3P75 9.8
ROIC-3.6
P25 -11.7P50 -0.2P75 8.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPEX/7595 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
175
Groups with data
11
Currency
TWD
Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Taiwan
Country code
TW
Employees Change
6%
Employees Change Percent
16.67
Enterprise value
TWD 1.1B
Exchange
Taipei Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Diagnostics & Research
Isin
TW0007595B13
Last refreshed
2026-05-10
Market cap
TWD 491.5M
Price
TWD 9.74
Price currency
TWD
Sector
Healthcare
Sic
2835
Symbol
tpex/7595
Website
https://pharmigene.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-14.85%
EV Earnings
-14.51x
EV/FCF
-14.06x
EV/Sales
5.3x
FCF yield
-15.33%
P/B ratio
1.77x
P/S ratio
2.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-27.49%
EBITDA Margin
-14.64%
Gross margin
28.23%
Gross Profit
TWD 56.4M
Gross Profit Growth
17.83%
Gross Profit Growth Q
34.92%
Gross Profit Growth3 Y
10.27%
Gross Profit Growth5 Y
3.25%
Net Income
TWD -73M
Net Income Growth Quarters
3%
Net Income Growth Years
1%
Pretax Margin
-36.5%
Profit Margin
-36.52%
ROA
-3.45
Roa5y
-4.8
ROCE
-6.47
ROE
-23.27
Roe5y
-16.09
ROIC
-3.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr1y
-19.52%
Cagr3y
-25.28%
Cagr5y
-16.08%
EPS Growth Quarters
3
EPS Growth Years
1
Revenue Growth
71.53x
Revenue Growth Q
68.23x
Revenue Growth Quarters
2x
Revenue Growth Years
1x
Revenue Growth3 Y
16.3x
Revenue Growth5 Y
8.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
TWD 0.2
Assets
TWD 988.4M
Cash
TWD 87.5M
Current Assets
TWD 178.1M
Current Liabilities
TWD 72.5M
Debt
TWD 655.1M
Debt Equity
TWD 2.35
Debt FCF
TWD -8.7
Equity
TWD 278.4M
Interest Coverage
-3.8
Liabilities
TWD 709.9M
Long Term Assets
TWD 810.3M
Long Term Liabilities
TWD 637.5M
Net Cash
TWD -567.6M
Net Cash By Market Cap
TWD -115
Net Debt Equity
TWD 2.04
Tangible Book Value
TWD 267.3M
Tangible Book Value Per Share
TWD 5.32
WACC
3.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.58
Inventory Turnover
2.93
Net Working Capital
TWD 78.4M
Quick ratio
1.02
Working Capital
TWD 80.6M
Working Capital Turnover
TWD 1.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
0.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-19.5%
200-day SMA
10.9
3Y total return
-58.29%
50-day SMA
10.13
50-day SMA vs 200-day SMA
50under200
5Y total return
-58.38%
All Time High
36
All Time High Change
-72.94%
All Time High Date
2020-12-22
All Time Low
9.35
All Time Low Change
4.17%
All Time Low Date
2026-04-24
ATR
0.41
Beta
0.08
Beta1y
-0.09
Beta2y
0.25
Ch YTD
-1.62
High
9.85
High52
14.1
High52 Date
2025-09-15
High52ch
-30.92%
Low
9.45
Low52
9.35
Low52 Date
2026-04-24
Low52ch
4.17%
Ma50ch
-3.88%
Price vs 200-day SMA
-10.62%
RSI
40.69
RSI Monthly
31.86
RSI Weekly
38.9
Sharpe ratio
-0.34x
Sortino ratio
-0.4
Total Return
0.37%
Tr YTD
-1.62
Tr1m
-4.51%
Tr1w
-2.5%
Tr3m
-7.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
TWD -55M
Operating margin
-27.49

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
29,824,583%
Net Borrowing
37,413,000
Shares Insiders
10.18%
Shares Out
50,465,000
Shares Qo Q
0%
Shares Yo Y
-0.37%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

49
MetricValue
Adjusted FCF
TWD -75.3M
Average Volume
43,502.6x
Bv Per Share
5.54
CAPEX
TWD -8.3M
Ch1m
-4.51
Ch1w
-2.5
Ch1y
-19.5
Ch3m
-7.24
Ch3y
-58.29
Ch5y
-58.38
Ch6m
-11.45
Change
-1.12%
Change From Open
-1.12
Close
9.85
Days Gap
0
Depreciation Amortization
25,701,000
Dollar Volume
187,816.4
Earnings Date
2026-05-11
EBIT
TWD -55M
EBITDA
TWD -29.3M
EPS
TWD -1.45
F Score
3
FCF
TWD -75.3M
FCF EV Yield
-7.11x
FCF Per Share
TWD -1.49
Financing CF
37,238,000
Fiscal Year End
December
Founded
1,994
Income Tax
TWD 25,000
Investing CF
-6,020,000
Is Primary Listing
1
Last Earnings Date
2025-11-11
Last Report Date
2025-06-30
Ma150
10.61
Ma150ch
-8.19%
Ma20
10.08
Ma20ch
-3.33%
Net CF
-35,856,000
Next Earnings Date
2026-05-11
Open
9.85
Position In Range
72.5
Ppne
546,265,000
Price Date
2026-05-08
Ptbv Ratio
1.84
Relative Volume
0.44x
Revenue
199,894,000x
Tax By Revenue
0.01x
Tr6m
-11.45%
Volume
19,283
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TPEX/7595 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/7595 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-19.5%
S&P 500 1Y: n/a
3Y total return
-58.3%
S&P 500 3Y: n/a
5Y total return
-58.4%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns TPEX/7595?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+10.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.4%
Negative means the company is buying back shares.
Technical

TPEX/7595 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
40.7
Neutral momentum band
Price vs 200-day MA
-10.6%
50/200-day relationship not available
Beta (5Y)
0.08
Less volatile than the market
Sharpe ratio
-0.34
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPEX/7595

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/7595 stock rating?

tpex/7595 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/7595 analysis?

The full report lives at /stocks/tpex/7595/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/7595?

The latest report frames tpex/7595 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/7595 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.